Child cancer drug approved for NHS use
60% of children with high-risk neuroblastoma can be treated with dinutuximab beta Related items fromOnMedica One in 10 children in phase I cancer trials respond to drugs Children need access to cancer drug ‘goldmine’ NICE rejects adjuvant use of breast cancer drug New breast cancer drug ‘unaffordable’ for NHS Drug could double head and neck cancer survival
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Children | Head and Neck Cancer | National Institute for Health and Clinical Excelle | Neuroblastoma | Neurology | UK Health